pharma · HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2–POSITIVE METASTATIC BREAST CANCER · Advanced HER2-Expressing Solid Tumors. · BOLT
Bolt Biotherapeutics
News and analysis for Bolt Biotherapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.
Redwood City, USA HQ
2015 Founded
51 Employees
Public company Type
BOLT · NYSE Ticker
Company details
- Status
- Public
- HQ
- Redwood City, USA
- Founded
- 2015
- Employees
- 51
- Programs
- 6
- Drugs
- 4
- Patents
- 7
News & analysis
NovaPharmaNews articles mentioning Bolt Biotherapeutics — regulatory, clinical, and market coverage.
News and analysis for Bolt Biotherapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.